{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["5(1)"],"submitter":["Fujiwara S"],"pubmed_abstract":["<h4>Unlabelled</h4><h4>Objectives</h4>G protein-coupled receptor 30 (GPR30) is a 7-transmembrane estrogen receptor that functions alongside traditional estrogen receptors to regulate the cellular responses to estrogen. Recent studies suggest that GPR30 expression is associated with a poor prognosis, and that this is due to the GPR30-mediated transactivation of the EGFR in breast cancer. However, the biological contribution of GPR30 in ovarian cancer remains unclear. The purpose of this study was to elucidate the relationships between GPR30 expression and the clinicopathological findings, and to determine how the signaling cascade influences the prognosis of ovarian cancer.<h4>Methods</h4>The expression levels of GPR30, EGFR, ERα, and ERβ were analyzed using an immunohistochemical analysis,"],"journal":["Journal of ovarian research"],"pagination":["35"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3543193"],"repository":["biostudies-literature"],"pubmed_title":["GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer."],"pmcid":["PMC3543193"],"pubmed_authors":["Sasaki H","Ohmichi M","Tsunetoh S","Takai M","Tanaka Y","Yamashita Y","Yoo S","Tanaka T","Fujiwara S","Terai Y","Kawaguchi H","Tanabe A","Kanemura M"],"additional_accession":[]},"is_claimable":false,"name":"GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer.","description":"<h4>Unlabelled</h4><h4>Objectives</h4>G protein-coupled receptor 30 (GPR30) is a 7-transmembrane estrogen receptor that functions alongside traditional estrogen receptors to regulate the cellular responses to estrogen. Recent studies suggest that GPR30 expression is associated with a poor prognosis, and that this is due to the GPR30-mediated transactivation of the EGFR in breast cancer. However, the biological contribution of GPR30 in ovarian cancer remains unclear. The purpose of this study was to elucidate the relationships between GPR30 expression and the clinicopathological findings, and to determine how the signaling cascade influences the prognosis of ovarian cancer.<h4>Methods</h4>The expression levels of GPR30, EGFR, ERα, and ERβ were analyzed using an immunohistochemical analysis,","dates":{"release":"2012-01-01T00:00:00Z","publication":"2012 Nov","modification":"2025-04-04T08:31:17.472Z","creation":"2019-03-27T01:03:15Z"},"accession":"S-EPMC3543193","cross_references":{"pubmed":["23163984"],"doi":["10.1186/1757-2215-5-35"]}}